🔎 Trials Near Me

Gara Jalqabaatti › Lymphoma B-Cell › Connecticut › New Haven

Qorannoo klinikaalii Lymphoma B-Cell New Haven, CT keessatti

Qorannoo 6 Lymphoma B-Cell f New Haven fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)

Namoota walitti qabaa jiraSadarkaa 3
  • Yale University Yale Cancer Center, New Haven
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT06742996

A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )

Namoota walitti qabaa jiraSadarkaa 1
  • Yale University School of Medicine - Yale Cancer Center, New Haven
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT07101328

Testing the Combination of Nivolumab and ASTX727 for Relapsed or Refractory B-Cell Lymphoma

Namoota walitti qabaa jiraSadarkaa 1
  • Yale University, New Haven
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 10-Ful-2026 · NCT05272384

A Study of ARV-393 in Relapsed/Refractory Non-Hodgkin Lymphoma.

Namoota walitti qabaa jiraSadarkaa 1
  • Clinical Trial Site, New Haven
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 04-Ful-2026 · NCT06393738

Mosunetuzumab With Lenalidomide Augmentation as First-line Therapy for Follicular and Marginal Zone Lymphoma

Namoota walitti qabaa jiraSadarkaa 2
  • Yale Cancer Center, New Haven
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 20-Hag-2026 · NCT04792502

DALY II USA/ MB-CART2019.1 for DLBCL

Namoota walitti qabaa jiraSadarkaa 2
  • Yale University, New Haven
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 13-Ado-2026 · NCT04792489

Qorannoo Lymphoma B-Cell magaalota biroo keessatti

Qorannoo biroo New Haven keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.